Jim Cramer: We Remain Excited About Abbott Laboratories for Action Alerts Plus

Jim Cramer explains why his Action Alerts Plus charitable portfolio is hanging on to Abbott Laboratories.
By Jim Cramer ,

TheStreet's founder and Action Alerts Plus portfolio manager Jim Cramer said he remains excited about Abbott Laboratories (ABT) - Get Report  because the opportunities presented by its new glucose monitoring system that doesn't requiring pricking one's fingers. Cramer added that its small competitor DexCom (DXCM) - Get Report doesn't stand much of a chance when put against Abbott's extensive resources. 

Watch More with TheStreet:

Loading ...